Picture of HealthStream logo

HSTM — HealthStream News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedMid CapHigh Flyer

HealthStream Q2 revenue up 4%

Overview

HealthStream Q2 revenue up 4% to $74.4 mln, meeting analyst expectations

Adjusted EBITDA for Q2 beats estimates, rising 11.3% to $17.6 mln

Co repurchased $18.1 mln in shares during Q2 as part of buyback program

Outlook

Company expects 2025 revenue between $297.5 mln and $303.5 mln

HealthStream projects 2025 net income of $19.5 mln to $22.4 mln

Company forecasts adjusted EBITDA of $68.5 mln to $72.5 mln for 2025

HealthStream anticipates capital expenditures of $31.0 mln to $34.0 mln in 2025

Result Drivers

SUBSCRIPTION REVENUES - Subscription revenues increased by $2.9 mln, contributing to overall revenue growth

SUBLEASE INCOME - Sublease income from a new lease commenced in Q2 2025 supported operating income growth

HIGHER EXPENSES - Increased costs for platform and SaaS investments partially offset revenue gains

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 RevenueMeet$74.40 mln$74.40 mln (5 Analysts)
Q2 EPS$0.18
Q2 Net Income$5.40 mln
Q2 Adjusted EBITDABeat$17.60 mln$17.30 mln (5 Analysts)
Q2 Capex$9.20 mln
Q2 Operating Income$5.90 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell" The average consensus recommendation for the software peer group is "buy" Wall Street's median 12-month price target for HealthStream Inc is $34.50, about 25.7% above its August 1 closing price of $25.65 The stock recently traded at 38 times the next 12-month earnings vs. a P/E of 50 three months ago Press Release: ID:nBw6WS6GPa (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on HealthStream

See all news